Our Latest Thinking

We are constantly scanning the health care market for new and interesting developments; then we write about them here. Check out our latest thinking.

States

Implications of the 2018 Midterm Elections

November 16th, 2018

Health care was a central issue in this year’s midterm elections. In the days after the election, many have speculated on what the results mean for U.S. health care policy. Since the Republicans maintained control of the Senate, while the Democrats took control of the House, some see the next two years as a time […]

Read More >

Medicaid Closed Drug Formularies: A Closed Door or a Path Forward?

October 2nd, 2018

As we noted in July, CMS declined Massachusetts’ Medicaid 1115 demonstration request to establish a closed formulary.  The proposed program would have given Massachusetts the ability to exclude certain FDA-approved drugs from coverage and thereby given the state additional leverage in negotiating rebates.  The state and drug manufacturers would have otherwise continued to be subject […]

Read More >

Leavitt Partners Releases “Evaluating the Performance of State Individual Markets Using the Individual Market Effectiveness Index” White Paper

September 27th, 2018

Salt Lake City, September 27, 2018 –Today, Leavitt Partners released “Evaluating the Performance of State Individual Markets Using the Individual Market Effectiveness Index,” a white paper that provides a more evidence-based approach for evaluating the performance of each state’s individual market. Since the Affordable Care Act’s passage, health care stakeholders, politicians, and consumers have scrutinized […]

Read More >

Evaluating the Performance of State Individual Markets Using the Individual Market Effectiveness Index

September 27th, 2018

Current efforts to effectively understand the individual market are often limited because they take a national rather than state view of the individual market. The individual market’s performance can vary significantly by state and meaningfully evaluating its performance requires a state-by-state examination. We developed the individual market effectiveness index (IMEI) to provide a more nuanced […]

Read More >

Medicaid Expansion Finds Grass-Roots Support in Conservative Utah

September 11th, 2018

Andrew Croshaw provided commentary on Utah’s Medicaid expansion ballot initiative for a New York Times article entitled “Medicaid Expansion Finds Grass-Roots Support in Conservative Utah.” “Polls suggest that the ballot measure is likely to pass,” said Andrew Croshaw, the chief executive of Leavitt Partners, a health care consulting firm founded by former Gov. Michael O. […]

Read More >

Medicaid ACOs on the Rise, but Differ Greatly Amongst States

August 20th, 2018

A Provider article entitled “Medicaid ACOs on the Rise, but Differ Greatly Amongst States” presents key findings and provides a brief overview of the four different types of Medicaid ACOs as described in the Leavitt Partners “Medicaid ACOs: Understanding Different State Approaches” white paper.

Read More >

A Uniquely American Health System

August 16th, 2018

As the United States continues to move toward a value-based health care system, significant challenges slow down our progress. Political pressure exists from all sides, incentives have yet to be appropriately aligned, and the pressing need to change stakeholder behavior remains a time-sensitive imperative. Solving these challenges requires going beyond admiring the challenges to implementing […]

Read More >

Medicaid ACOs: Understanding Different State Approaches

August 14th, 2018

Medicaid accountable care organizations (ACOs) differ from state to state. To understand these differences, Leavitt Partners developed a framework that explains four approaches states take to establish ACO programs. The framework considers the level of state engagement with the ACO based on whether a Medicaid managed care organization (MCO) exists in the state and the MCO’s degree of involvement. The framework can […]

Read More >